Amylyx is developing AMX0035 to improve the lives of people living with ALS, Alzheimer’s and other diseases of the brain. AMX0035 is a drug designed to prevent nerve cell death and degeneration. The drug improved cellular metabolism and promoted protein folding in cellular and animal models of neurodegenerative disease. When metabolism and protein folding are not functioning properly, neurons halt key functions and ultimatel...
Amylyx is developing AMX0035 to improve the lives of people living with ALS, Alzheimer’s and other diseases of the brain. AMX0035 is a drug designed to prevent nerve cell death and degeneration. The drug improved cellular metabolism and promoted protein folding in cellular and animal models of neurodegenerative disease. When metabolism and protein folding are not functioning properly, neurons halt key functions and ultimately can die. Metabolism and protein folding appear to be dysfunctional in ALS, Alzheimer’s and other neurological diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.